特发性身材矮小儿童选择性生长激素治疗的伦理问题。
The Ethics of Elective Growth Hormone Therapy in Children with Idiopathic Short Stature.
机构信息
MD Candidate 2024, Faculty of Medicine, Memorial University of Newfoundland, St. John's, Newfoundland and Labrador, Canada.
Assistant Professor and Clinical Ethics Consultant at Alden March Bioethics Institute, Albany Medical College, Albany, New York USA.
出版信息
J Clin Ethics. 2021 Fall;32(3):206-214.
PMID:34548429
Abstract
In this article, we analyze the ethics of elective growth hormone (GH) therapy in children with idiopathic short stature (ISS). We discuss recent clinical research regarding the efficacy, side-effects, and risks of GH therapy, and argue that GH therapy is ethically unjustifiable for most children with ISS.
摘要
在这篇文章中，我们分析了特发性身材矮小症（ISS）儿童选择性生长激素（GH）治疗的伦理问题。我们讨论了最近关于 GH 治疗的疗效、副作用和风险的临床研究，并认为 GH 治疗对大多数 ISS 儿童在伦理上是不合理的。
Zotero 插件